
10,000+ employees
💊 Pharmaceuticals
🏥 Healthcare
🧬 Biotechnology
💰 $6.5M Post-IPO Debt - Eli Lilly on 2024-02
Pharmaceuticals • Healthcare • Biotechnology
Eli Lilly and Company is a multinational pharmaceutical company that researches, develops, manufactures, and markets prescription medicines across multiple therapeutic areas including diabetes, oncology, immunology, neuroscience, and pain. Headquartered in Indianapolis, Indiana, Lilly is known for its extensive R&D, clinical development, and global commercialization of biologic and small-molecule drugs. The company focuses on drug discovery, clinical trials, regulatory approvals, and large-scale pharmaceutical manufacturing and distribution.
🕒 June 27
Improve your chances of getting an interview by checking your resume score before you apply.

10,000+ employees
💊 Pharmaceuticals
🏥 Healthcare
🧬 Biotechnology
💰 $6.5M Post-IPO Debt - Eli Lilly on 2024-02
Pharmaceuticals • Healthcare • Biotechnology
Eli Lilly and Company is a multinational pharmaceutical company that researches, develops, manufactures, and markets prescription medicines across multiple therapeutic areas including diabetes, oncology, immunology, neuroscience, and pain. Headquartered in Indianapolis, Indiana, Lilly is known for its extensive R&D, clinical development, and global commercialization of biologic and small-molecule drugs. The company focuses on drug discovery, clinical trials, regulatory approvals, and large-scale pharmaceutical manufacturing and distribution.
• Lead end-to-end commercial assessment for licensing, acquisition, and partnership opportunities across markets • Build the forecasting infrastructure that raises the quality of BD analytics across the organization • Lead commercial assessments from early landscape scoping through full deal-stage forecasting • Rapidly develop substantive expertise in unfamiliar therapeutic areas • Design and lead primary research programs (qualitative and quantitative) with physicians, payers, patients, and channel partners • Build Lilly's institutional knowledge base in new markets through documented findings, assumptions, and forecast rationale that persist beyond individual deals • Build flexible, reusable forecasting models with modular architecture, shared assumptions, and clear documentation • Evaluate innovative commercial approaches — outcomes-based contracting, risk-sharing structures, novel launch sequencing — and assess their viability in new market entries • Serve as the commercial analytics partner to BD leadership from initial screening through due diligence, term sheet development, and integration planning • Present forecasts to senior executives with the confidence to defend assumptions, acknowledge uncertainty honestly, and make clear recommendations
• Bachelor's or advanced degree in a scientific field • 10+ years in pharmaceutical or biotech commercial strategy, BD analytics, market research, or strategic forecasting • Meaningful exposure beyond a single therapeutic area • Demonstrated track record building commercial conviction in new or ambiguous markets — not just maintaining existing forecasts • Experience leading primary market research: study design, vendor management, and synthesis into commercial recommendations • Strong financial modeling skills: bottoms-up and epidemiology-based revenue forecasting, DCF/rNPV analysis, sensitivity and scenario modeling • Deep understanding of how pharmaceutical markets work: treatment paradigm dynamics, prescriber behavior, payer decision-making, launch benchmarks, competitive response • Familiarity with innovative go-to-market models (value-based agreements, outcomes-based contracting, digital-first launch) and pharmaceutical channel architecture • Confident communicator who can present a supported commercial view to senior leadership and stand behind it • Strategy consulting or life sciences investment banking background; experience with RWE/HEOR; knowledge of FDA/EMA regulatory pathways; prior work building forecasting infrastructure across a BD organization
• eligibility to participate in a company-sponsored 401(k) • pension • vacation benefits • eligibility for medical, dental, vision and prescription drug benefits • flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts) • life insurance and death benefits • certain time off and leave of absence benefits • well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Apply Now🕒 June 27
Health Systems Executive at QIAGEN responsible for managing enterprise accounts and driving revenue growth across healthcare IDNs. Collaborating with various internal teams and strategic partners while focusing on long-term partnerships.
🇺🇸 United States – Remote
💵 $130k - $170k / year
🔥 Funding within the last year
💰 $750M Post-IPO Debt - Qiagen on 2025-08
⏰ Full Time
🟠 Senior
👔 Director
🕒 June 27
Senior Director overseeing the Enterprise PMO to drive strategic initiatives in a SaaS organization. Leading a team and fostering innovation to meet organizational objectives.
🕒 June 26
Senior Director shaping organizational effectiveness and capabilities at Travere Therapeutics, a biopharmaceutical company supporting rare disease community. Partnering with leaders to advance workforce strategies and organizational design.
🕒 June 26
5001 - 10000
Lead Blue Yonder’s ISV partner strategy and global partnerships. Drive measurable pipeline and revenue outcomes while collaborating with cross-functional teams.
🕒 June 26
Associate Director of Speaker Programs at Natera, leading healthcare education and compliance initiatives. Overseeing operations for peer-to-peer physician education programs across multiple business units.